2003
DOI: 10.1210/me.2002-0310
|View full text |Cite
|
Sign up to set email alerts
|

Determination of Nuclear Receptor Corepressor Interactions with the Thyroid Hormone Receptor

Abstract: The thyroid hormone receptor (TR) recruits the nuclear corepressors, nuclear receptor corepressor (NCoR) and silencing mediator of retinoid and thyroid hormone receptors (SMRT), to target DNA elements in the absence of ligand. While the TR preferentially recruits NCoR, the mechanism remains unclear. The corepressors interact with the TR via interacting domains (IDs) present in their C terminus which contain a conserved motif termed a CoRNR box. Despite their similarity, the corepressor IDs allow for nuclear re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
62
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 73 publications
(70 citation statements)
references
References 37 publications
8
62
0
Order By: Relevance
“…Others have reported that the R429Q mutant TR is impaired for silencing mediator of retinoid and thyroid receptors (SMRT) release in vitro (42), a functional property that has recently been reported in conjunction with deficient NCoR binding in another TR-␤ mutant (Mkar) discovered in a patient with predominantly central RTH (43). However, it is unlikely that the observed specific defect in TH negative regulation with the R429Q mutant is due to defective SMRT release, given that (i) NCoR is the corepressor preferentially recruited by TR-␤ (44,45), (ii) we were unable to detect R429Q TR binding to SMRT in EMSA (data not shown), and (iii) Mkar had defective TH function on both positive and negative TH response elements.…”
Section: Discussionmentioning
confidence: 99%
“…Others have reported that the R429Q mutant TR is impaired for silencing mediator of retinoid and thyroid receptors (SMRT) release in vitro (42), a functional property that has recently been reported in conjunction with deficient NCoR binding in another TR-␤ mutant (Mkar) discovered in a patient with predominantly central RTH (43). However, it is unlikely that the observed specific defect in TH negative regulation with the R429Q mutant is due to defective SMRT release, given that (i) NCoR is the corepressor preferentially recruited by TR-␤ (44,45), (ii) we were unable to detect R429Q TR binding to SMRT in EMSA (data not shown), and (iii) Mkar had defective TH function on both positive and negative TH response elements.…”
Section: Discussionmentioning
confidence: 99%
“…Exogenous TH could overcome this inhibition if it induced dissociation of receptor heterodimers prematurely, before the gradient of thyroid hormone becomes established. Thyroid hormone receptors mediate repression (usually in the absence of ligand) by interacting with nuclear co-repressors NCoR and/or SMRT (Eckey et al, 2003;Makowski et al, 2003;Havis et al, 2006). In fact, a growing body of evidence indicates that heterodimers of thyroid hormone and Rxr receptors adopt different configurations based on information provided by the DNA binding site with which they associate, that facilitate or block interactions with co-activators or co-repressors [ (Harvey et al, 2007) and references cited therein; (Ghosh et al, 2002;Diallo et al, 2007)].…”
Section: Trβ2 Is a Positive Regulator For M-conesmentioning
confidence: 99%
“…Despite their similarity the RIDs do not function equivalently. TR has been shown to preferably bind NCoR both in vitro and in mammalian cell lines (22,23) via the most 5Ј of its RIDs, N3, which is required for strong interactions with DNA-bound TR (18,21,24). Importantly, N3 must cooperate with another RID, preferably N2, to interact with a TR homodimer on DNA as each TR binds to 1 of the RIDs (18,(21)(22)(23)(24)(25).…”
mentioning
confidence: 99%